| NDC Code | 73475-3102-3 |
|---|
| Package Description | 1 VIAL, SINGLE-DOSE in 1 CARTON (73475-3102-3) / 5.6 mL in 1 VIAL, SINGLE-DOSE |
|---|
| Product NDC | 73475-3102 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Vyvgart Hytrulo |
|---|
| Non-Proprietary Name | Efgartigimod Alfa And Hyaluronidase (human Recombinant) |
|---|
| Dosage Form | INJECTION, SOLUTION |
|---|
| Usage | SUBCUTANEOUS |
|---|
| Start Marketing Date | 20230620 |
|---|
| Marketing Category Name | BLA |
|---|
| Application Number | BLA761304 |
|---|
| Manufacturer | argenx US |
|---|
| Substance Name | EFGARTIGIMOD ALFA; HYALURONIDASE (HUMAN RECOMBINANT) |
|---|
| Strength | 180; 2000 |
|---|
| Strength Unit | mg/mL; U/mL |
|---|
| Pharmacy Classes | Endoglycosidase [EPC], Glycoside Hydrolases [CS], Neonatal Fc Receptor Blocker [EPC], Neonatal Fc Receptor Blockers [MoA] |
|---|